Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Methylprednisolone sodium succinate

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Methylprednisolone Sodium Succinate is a corticosteroid medication available as an injectable powder for solution. It helps reduce inflammation, swelling, and immune responses in conditions like arthritis, allergies, and certain diseases. Administered by intramuscular or intravenous injection in strengths from 40 mg to 2 g per vial. Manufactured by Eugia US LLC under ANDA207667. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov